PRTK - Paratek Pharmaceuticals Inc. (PRTK) CEO Evan Loh on Q1 2022 Results - Earnings Call Transcript
Paratek Pharmaceuticals, Inc. (PRTK) Q1 2022 Earnings Conference Call May 04, 2022, 4:30 PM ET Company Participants Evan Loh - CEO Sarah Higgins - Vice President Finance Controller Adam Woodrow - President and Chief Commercial Officer Randy Brenner - Chief Development and Regulatory Officer Conference Call Participants Suji Jeong - Jefferies Robert Hazlett - BTIG Ed Arce - H.C. Wainwright Presentation Operator Good afternoon. And welcome to Paratek Pharmaceuticals, First Quarter 2022 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there'll be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Sarah Higgins, Vice President of Finance. Please go ahead. Sarah Higgins Good afternoon and welcome to Paratek's first quarter 2022 earnings and corporate update conference call. The press release with the company's financial results was issued earlier today,
For further details see:
Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q1 2022 Results - Earnings Call Transcript